Author:
Mundy Linda,Merlin Tracy L,Parrella Adriana,Babidge Wendy J,Roberts Dianne E,Hiller Janet E
Abstract
UP UNTIL 1982, new health technologies, procedures
or services were introduced into the health
system in an uncontrolled, unregulated manner.
This had the potential for wide-ranging impact on
the public health care system including ballooning
costs, a lack of preparedness by training and
accreditation organisations, and consequent patient
safety concerns. Health technology assessment was
introduced into Australia in 1982 when the
National Health Technology Assessment Panel was
formed. This original panel has undergone numerous
name changes and evolved into the Australian
Government-funded Medical Services Advisory
Committee (MSAC).1 The primary role of the
MSAC is to inform the Federal Minister for Health
and Ageing on the safety, effectiveness and costeffectiveness
of new medical technologies and procedures
using the available evidence.2 Assessments
of the safety, effectiveness and cost-effectiveness of
these technologies may occur only after the technology
has diffused and is practised widely.3 Early
identification of such technologies may avoid the
detrimental consequences of their indiscriminate
introduction and could result in the adoption of
beneficial and cost-effective technologies and the
elimination of technologies that are unsafe or for
which there is no evidence of cost-effectiveness.4
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献